CELLDATA DNAstorm™/RNAstorm™ 2.0 Combination Kit
A combination kit for dual extraction of DNA and RNA from a single FFPE sample, featuring proprietary CAT5™ technology.
Wishlist updated! View wishlist
Product Description
Formalin-fixed tissue samples are a challenge for nucleic acid extraction, often resulting in low yields of amplifiable DNA/RNA and poor performance in subsequent steps involving enzymatic manipulation, including reverse transcription and sequencing library preparation. Powered by proprietary CAT5™ technology, the CELLDATA DNAstorm™/RNAstorm™ 2.0 Combination Kit enhances the removal of formaldehyde-induced damage and provides dual DNA and RNA extraction with higher yield and quality. This allows for improved amplifiability for applications such as RNA-seq, qPCR, microarray, or other gene expression analysis.
- Extract higher yields of DNA and RNA from a single FFPE tissue sample
- CAT5™ technology for chemical reversal of formaldehyde crosslinking
- Milder conditions and no harsh solvents
- Higher quality DNA/RNA with less fragmentation
- Better results in downstream analysis like PCR, microarray, or next-generation sequencing
- Simple spin column-based workflow
Note: This kit is a replacement for catalog number CD503. It uses a modified deparaffinization protocol with a new Dewaxing Solution (provided in the kit). The new kit retains the same proprietary CAT5™ catalytic technology for highly efficient reversal of formaldehyde crosslinks as the original kit.
For extracting either RNA or DNA from FFPE tissues, please see our CELLDATA RNAstorm™ 2.0 FFPE RNA Extraction Kit (CD506) and CELLDATA DNAstorm™ 2.0 FFPE DNA Extraction Kit (CD507). We also offer the RNAstorm™ RNA Isolation Kit for purifying RNA from fresh or frozen cells/tissue samples.
References
- bioRxiv (2020) doi: https://doi.org/10.1101/2020.06.02.130096
- Virchows Arch (2020) doi: https://doi.org/10.1007/s00428-020-02838-0
- bioRxiv (2020) doi: https://doi.org/10.1101/2020.02.24.963652
- J Mol Diagnost (2020) 22(4) 555-570. https://doi.org/10.1016/j.jmoldx.2020.01.009
- J Neurosurg (2020) 14, 1-9. doi: 10.3171/2019.12.JNS192155
- Lung Cancer (2020) 139, 1-8. https://doi.org/10.1016/j.lungcan.2019.10.012
- Oral Oncol (2020) 100, 104487. https://doi.org/10.1016/j.oraloncology.2019.104487
- World Neurosurg (2020). https://doi.org/10.1016/j.wneu.2020.03.112
- J Exp Med (2020) 217 (6): e20191787. https://doi.org/10.1084/jem.20191787
- Am J Surg Pathol, 43, 1720 DOI: 10.1097/PAS.0000000000001338